Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

cafead

Administrator
Staff member
  • cafead   Feb 12, 2025 at 09:52: PM
via
  • It crushed analyst estimates on both the top and bottom lines.
  • This, despite significant erosion in both metrics.

article source